The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

Drug Treatment of Chronic Ambulatory Patients

Published Online:https://doi.org/10.1176/ajp.123.11.1329

The introduction and widespread use of psychotropic drugs have raised many problems for the community physician. The private practitioner (whether psychiatrist or general practitioner) should be alert to problems of safety, toxicity, and side effects. Unless he is an expert in psychopharmacology, he should restrict himself to prescribing only a small number of drugs and should determine by clinical trial the optimal dosage for each patient.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.